We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Biocitech Welcomes Helios BioSciences to its Technology Park

News   Mar 07, 2012

 
Biocitech Welcomes Helios BioSciences to its Technology Park
 
 
 

RELATED ARTICLES

Minimizing Toxicity of Breast Cancer Treatment

News

De-escalation of treatment strategies aims to minimize toxicity while maintaining efficacy.

READ MORE

Two HPV Types Linked to Cervical Cancer Have Declined Since Arrival of the HPV Vaccine

News

An analysis of cervical precancers over a period of seven years showed that two strains of human papillomavirus (HPV) that have been targeted by vaccination since 2006 have declined, accounting for a smaller proportion of cervical disease, according to newly published research.

READ MORE

Paradigm Shift for Design of Universal Vaccines

News

Killer T cells have been identified that can fight all influenza viruses – A, B and C – creating the potential for the development of a world-first universal, one-shot flu vaccine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE